2018 low / high-end revenue forecastsThis is my third Table, with more crunchy figures...
As stated by the 'Technology market watch' Jpurnal, 2018 revenues should be much higher with the KSA contract.
Here is my crystal ball figures, based on the two previous tables (earlier posts) showing the previous years records and trends.
Indeed, revenues from CARA only should range between 6 and 10 million $ in 2018 ... ! 3-4 times what we had in 2017. Not bad...
Have fun!
Keep investing wisely!
| ADK CARA targets: patients tested -- low / high-end forecasts | | | |
| (est./ fiscal yr.) | | | | | | |
| | 2015 - 2017 | ADK Patients | Lower-end | forecast | Higher-end | forecast |
| | ADK Revenue | tested (E) | ADK Patients | ADK Earnings | ADK Patients | ADK Earnings |
| | per patient (E) | 2015 - 2017 | FY 2018 (E) | 2018 potential | FY 2018 (E) | 2018 potential |
| | | | | | | |
| India | 5,01 $ | 61 200 | 75 000 | 375 751 $ | 100 000 | 501 002 $ |
| United Arab Emirates | 11,07 $ | 63 200 | 6 000 | 66 431 $ | 10 000 | 110 718 $ |
| Switzerland | 13,39 $ | 4 500 | 2 000 | 26 778 $ | 3 000 | 40 166 $ |
| USA | 13,40 $ | 5 550 | 6 000 | 80 371 $ | 10 000 | 133 951 $ |
| Algeria | 13,00 $ | 7 000 | 7 000 | 91 000 $ | 8 000 | 104 000 $ |
| Argentina | 13,00 $ | 5 000 | 4 000 | 52 000 $ | 5 000 | 65 000 $ |
| Canada | 13,00 $ | 2 000 | 6 000 | 78 000 $ | 10 000 | 130 000 $ |
| Mexico | 11,85 $ | 106 000 | 150 000 | 1 776 859 $ | 200 000 | 2 369 145 $ |
| Poland | 12,58 $ | 3 100 | 1 500 | 18 864 $ | 2 000 | 25 152 $ |
| Turkey | 11,88 $ | 4 000 | 6 000 | 71 288 $ | 8 000 | 95 050 $ |
| Colombia | 10,86 $ | 1 100 | 1 000 | 10 861 $ | 1 500 | 16 291 $ |
| Kenya | 12,10 $ | 3 000 | 3 000 | 36 297 $ | 5 000 | 60 495 $ |
| Malaysia | 11,00 $ | 1 500 | 3 000 | 33 000 $ | 5 000 | 55 000 $ |
| Nigeria | 11,00 $ | 0 | 3 000 | 33 000 $ | 5 000 | 55 000 $ |
| Saudi Arabia | 13,00 $ | 0 | 300 000 | 3 900 000 $ | 500 000 | 6 500 000 $ |
| | 12,90 $ | 267 150 | 573 500 | 6 650 499 $ | 872 500 | 10 260 971 $ |